Zimmer Biomet Holdings, Inc. (BVMF:Z1BH34)

Market Cap	91.83B
Revenue (ttm)	42.69B
Net Income (ttm)	4.29B
Shares Out	n/a
EPS (ttm)	21.49
PE Ratio	21.40
Forward PE	10.42
Dividend	0.89 (0.77%)
Ex-Dividend Date	Dec 29, 2025

Volume	20
Average Volume	52
Open	123.70
Previous Close	n/a
Day's Range	116.24 - 123.70
52-Week Range	115.00 - 157.60
Beta	0.61
RSI	34.06
Earnings Date	Feb 10, 2026

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open hear...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1927
• Employees: 17,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: Z1BH34

Financial Performance

In 2024, Zimmer Biomet Holdings's revenue was $7.68 billion, an increase of 3.85% compared to the previous year's $7.39 billion. Earnings were $903.80 million, a decrease of -11.74%.

Financial numbers in USD